Dataset Information

Prediction of unconventional protein secretion by exosomes.

ABSTRACT:

Motivation

In eukaryotes, proteins targeted for secretion contain a signal peptide, which allows them to proceed through the conventional ER/Golgi-dependent pathway. However, an important number of proteins lacking a signal peptide can be secreted through unconventional routes, including that mediated by exosomes. Currently, no method is available to predict protein secretion via exosomes.

Results

Here, we first assembled a dataset including the sequences of 2992 proteins secreted by exosomes and 2961 proteins that are not secreted by exosomes. Subsequently, we trained different random forests models on feature vectors derived from the sequences in this dataset. In tenfold cross-validation, the best model was trained on dipeptide composition, reaching an accuracy of 69.88% ± 2.08 and an area under the curve (AUC) of 0.76 ± 0.03. In an independent dataset, this model reached an accuracy of 75.73% and an AUC of 0.840. After these results, we developed ExoPred, a web-based tool that uses random forests to predict protein secretion by exosomes.

Conclusion

ExoPred is available for free public use at http://imath.med.ucm.es/exopred/ . Datasets are available at http://imath.med.ucm.es/exopred/datasets/ .

SUBMITTER: Ras-Carmona A

PROVIDER: S-EPMC8210391 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:Protein secretion is an essential process in cell biology. The conventional secretion pathway is well known, and involves proteins with a signal sequence being directed into the endoplasmic reticulum. Once in the lumen of the endoplasmic reticulum, proteins are trafficked through the Golgi and remain separate from the cytosol throughout their journey to the outside of the cell. More recently, proteins without a signal sequence have been found outside the cell. These proteins are secreted unconventionally, and avoid the ER-Golgi route. For both pathways, some aspects remain unclear, particularly surrounding the regulation of protein secretion. Galectin-3, an unconventionally secreted protein, was used here to investigate both conventional and unconventional protein secretion. The unconventional protein secretion of galectin-3 is poorly understood. To address this, genetic manipulation of galectin-3 was used to gain insights into the mechanism of galectin-3 secretion. It was found that galectin-3 does not require unfolding or binding to cell surface glycoproteins to be secreted. Galectin-3 was also used to assess protein secretion using a genome-wide CRISPR screen. As galectin‑3 binds to cell surface glycoproteins, galectin-3 on the cell surface was used to assess secretion of these glycoproteins. Hits were validated by a glycoprotein secretion assay. Using this pipeline, 93 hits were identified as involved in protein secretion, of which 51 were novel hits not previously associated with protein secretion. Many of the hits identified also resulted in a phenotype of altered Golgi morphology, and five of these were investigated further. Two novel hits that localised to the Golgi were identified, TMEM220 and GPR161. GPR161 likely mediates its effect on Golgi morphology by its interaction with golgin A5. This thesis presents new insights into both conventional and unconventional protein secretion. Insights into the mechanism for galaectin-3 secretion were revealed. A novel Golgi-localised regulator of secretion, GRP161, was identified, with a mechanism for action suggested. Importantly, the list of 51 novel genes identified will serve as a useful resource for other researchers investigating protein secretion.

Project description:After reporting that mice with inducible CM-specific Wnt activation (β-catΔex3) mimic pathological remodelling condition and heart failure, we further explored the cardiac-derived extracellular vesicles (EVs). EVs analysis in vivo are challenging, therefore we used a genetic model to analyze the extracellular compartment as well as the cell composition in vivo, which provided advantageous by focusing only on the relative changes between control and transgenic cells. With an improved protocol we isolated EVs from CT and β-catΔex3 hearts. The fraction containing small EVs was confirmed by electron microscopy and nanoparticle-tracking-analysis and further characterized with EV, endoplasmic reticulum and Golgi markers as well as mass spectrometry analysis. This analysis confirmed the cardiac origin of EVs and showed 47% proteins included in Exocarta Top100 candidate with a major exosome (Exo) representation. By proteomic analysis, 391 significantly differentially enriched proteins in β-catΔex3 hearts were identified, which were significantly loaded with all seven α and β chains of the constitute 20S proteasome, molecular chaperones and co-chaperones as well as proteasome associated proteins previously described in Exo (HSPA70, HSP90AB1, CRYAB, PKACA and BAG2). CRYAB, a cardiac chaperone protein that triages misfolded proteins for proteasomal degradation or repair, was confirmed to co-localize with labelled Exo in vitro. We performed single whole cell transcriptome, followed by pairwise comparison of differential expressed gene analysis (DEG) and their functional enrichment between β-catΔex3 and CT cell clusters. This revealed that different cardiomyocytes and endothelial cell subpopulations of β-catΔex3 CM were significantly active transcriptional activity of EVs secretion and protein quality control pathways. This finding was confirmed in cardiomyocytes populations of old mice subjected to experimental pressure overload to induce hypertrophy at early and late stages of remodeling, including an acute early upregulation of exosome biogenesis processes and chaperons transcripts including CRYAB at early stages. In order to model this molecular mechanism in human cells, human induced pluripotent stem cells (IPSC)-derived cardiomyocytes were subjected to pharmacological Wnt activation, which recapitulated the increased cell cycle activation as well as exosomal markers in vitro. Our results indicate a contribution of Exo-mediated maintenance of cardiomyocytes proteostasis upon pathological remodeling. Upon stress, CRYAB and co-chaperones increase binding to damaged-sarcomeric-proteins heading towards degradation, which overload the intracellular proteasomal capacity. This may activate EV-mediated cellular extrusion of misfolded proteins as a mechanism of cellular protection. Cardiac extracellular proteosome may serve as read-out of disease progression and for monitoring cellular remodeling in vivo.